Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis.

about

Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q41930841

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Risk of developing antiphospho ...... atic review and meta-analysis.

@en

type

Item

label

Risk of developing antiphospho ...... atic review and meta-analysis.

@en

prefLabel

Risk of developing antiphospho ...... atic review and meta-analysis.

@en

P1476

Risk of developing antiphospho ...... matic review and meta-analysis

@en

P2093

M A Lopez-Olivo

http://www.w3.org/2001/XMLSchema#string

M E Suarez-Almazor

http://www.w3.org/2001/XMLSchema#string

N Abdel-Wahab

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

Bias in meta-analysis detected by a simple, graphical test

A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Systematic review of case reports of antiphospholipid syndrome following infection.

High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications.

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome.

Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients.

P304

572-583

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1177/0961203317731532

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Saurabh Talathi

P577

2017-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28945149

http://www.w3.org/2001/XMLSchema#string